new glp-1 agonists Upcoming wave of hormone-based therapies set to change field of diabetes, obesity care new glp 1 agonist In

GLP-1 works beautifullystimulating insulin, suppressing glucagon, and slowing gastric emptyingbut it has a fatal flaw: It is destroyed by the enzyme DPP-4 within minutes of entering the bloodstream

Patients experience abnormal stomach movement that lasts at least three months

Clinical Implications Patients taking GLP-1-RA may be at an increased risk for aspiration of gastric contents because of delayed gastric emptying, even if proper preoperative fasting guidelines have been followed

doi: 10.1016/j.cmet.2016.06.009 9 KappeCTracyLMPatroneCIverfeldtKSjholm

DOC News-American Diabetes Association

It is probable that the fat loss alone is causing these benefits